Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (6): 9-16.doi: 10.6040/j.issn.1671-7554.0.2023.1040

• Preclinical Medicine • Previous Articles    

Role of microfibril-associated protein 3 in regulating mesenchymal transition of glioma stem cells

GUO Shuhua1,2, FAN Yang3, TIAN Feng1,2, WANG Chuanxin1,2, DU Lutao1,2, LI Peilong1,2, GUO Xing1,4, XU Shuo1,4   

  1. 1. Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China;
    2. Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan 250033, Shandong, China;
    3. Department of Neurosurgery, The First Affiliated Hospital of Shandong First Medical University &
    Shandong Provincial Qianfoshan Hospital, Jinan 250014, Shandong, China;
    4. Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2024-07-15

PDF (PC)

119

Abstract: Objective To investigate the expression and clinical significance of microfibril-associated protein 3(MFAP3)in glioblastoma(GBM)and its influence on the malignant biological behavior of glioma stem cells(GSCs). Methods TCGA data and CGGA data were used to analyze the expression of MFAP3 in GBM and its correlation with patient prognosis. Western blotting was used to detect the protein expression level of MFAP3 in GSCs. The effects of MFAP3 knockdown and overexpression on the self-renewal ability and phenotype of GSCs were explored. Results MFAP3 was highly expressed in GBM and correlated with poor prognosis. The expression level of MFAP3 in mesenchymal GSCs was higher than that in preneuronal GSCs. After MFAP3 knockdown, the self-renewal ability of GSCs was weakened, and the protein levels of mesenchymal phenotype markers CD44 and YKL40 were decreased, whereas overexpression exhibited the opposite trends. Conclusion MFAP3 plays an important role in regulating the malignant biological progression of GBM and is expected to be a new clinical diagnostic marker and therapeutic intervention target for GBM.

Key words: Microfibril-associated protein 3, Glioma stem cells, Phenotype transition, Self-renewal, Prognosis

CLC Number: 

  • R739.41
[1] Alexander BM, Cloughesy TF. Adult glioblastoma[J]. J Clin Oncol, 2017, 35(21): 2402-2409.
[2] Huang BY, Li XS, Li YT, et al. Current immunotherapies for glioblastoma multiforme[J]. Front Immunol, 2021, 11: 603911. doi:10.3389/fimmu.2020.603911.
[3] Lah TT, Novak M, Breznik B. Brain malignancies: glioblastoma and brain metastases[J]. Semin Cancer Bio, 2020, 60: 262-273. doi: 10.1016/j.semcancer.2019.10.010.
[4] Tan AC, Ashley DM, López GY, et al. Management of glioblastoma: state of the art and future directions[J]. CA Cancer J Clin, 2020, 70(4): 299-312.
[5] Shaim H, Shanley M, Basar R, et al. Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells[J]. J Clin Invest, 2021, 131(14): e142116. doi:10.1172/JCI142116.
[6] Mohile NA, Messersmith H, Gatson NT, et al. Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline[J]. J Clin Oncol, 2022, 40(4): 403-426.
[7] Suvà ML, Tirosh I. The glioma stem cell model in the era of single-cell genomics[J]. Cancer Cell, 2020, 37(5): 630-636.
[8] Fan Y, Gao ZJ, Xu JY, et al. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages[J]. Theranostics, 2023, 13(10): 3310-3329.
[9] Gao ZJ, Xu JY, Fan Y, et al. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells[J]. J Exp Clin Cancer Res, 2022, 41(1): 323. doi:10.1186/s13046-022-02526-8.
[10] Chen ZH, Wang HZ, Zhang ZP, et al. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells[J]. J Exp Clin Cancer Res, 2021, 40(1): 20. doi:10.1186/s13046-020-01807-4.
[11] Gao ZJ, Xu JY, Fan Y, et al. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition[J]. J Exp Clin Cancer Res, 2022, 41(1): 223. doi:10.1186/s13046-022-02431-0.
[12] Zhu SP, Ye L, Bennett S, et al. Molecular structure and function of microfibrillar-associated proteins in skeletal and metabolic disorders and cancers[J]. J Cell Physiol, 2021, 236(1): 41-48.
[13] Olson JE, Wang X, Goode EL, et al. Variation in genes required for normal mitosis and risk of breast cancer[J]. Breast Cancer Res Treat, 2010, 119(2): 423-430.
[14] Li M, Zhang HY, Zhang RG. MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating autophagy[J]. PeerJ, 2023, 11: e15441. doi:10.7717/peerj.15441.
[15] Zhang H, Shen S, Feng C, et al. MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy[J]. Acta Biochim Biophys Sin, 2023, 55(9): 1445-1455.
[16] Han Y, Xia K, Su T. Exploration of the important role of microfibril-associated protein 4 gene in oral squamous cell carcinoma[J]. Med Sci Monit, 2021, 27: e931238. doi:10.12659/MSM.931238.
[17] Li J, Wang JG, Liu ZK, et al. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma[J]. J Cancer Res Ther, 2022, 18(7): 1919-1925.
[18] Zhou Z, Cui D, Sun MH, et al. CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling[J]. FASEB J, 2020, 34(6): 7970-7988.
[19] Duan Y, Zhang XZ, Ying HG, et al. Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix[J]. Oncogene, 2023, 42(25): 2061-2073.
[20] Abrams WR, Ma RI, Kucich U, et al. Molecular cloning of the microfibrillar protein MFAP3 and assignment of the gene to human chromosome 5q32-q33.2[J]. Genomics, 1995, 26(1): 47-54.
[21] Uddin MN, Wang XS. Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer[J]. Breast Cancer, 2022, 29(3): 541-561.
[22] Lou XM, Kang B, Zhang J, et al. MFAP3L activation promotes colorectal cancer cell invasion and metastasis[J]. Biochim Biophys Acta, 2014, 1842(9): 1423-1432.
[23] Ye JH, Luo WJ, Luo LL, et al. MicroRNA-671-5p inhibits cell proliferation, migration and invasion in non-small cell lung cancer by targeting MFAP3L[J]. Mol Med Rep, 2022, 25(1): 30. doi:10.3892/mmr.2021.12546.
[24] Jiang L, Hao YJ, Shao CW, et al. ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance[J]. J Clin Invest, 2022, 132(6): e143397. doi:10.1172/JCI143397.
[25] Dixit D, Prager BC, Gimple RC, et al. The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells[J]. Cancer Discov, 2021, 11(2): 480-499.
[26] Joseph JV, Conroy S, Pavlov K, et al. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis[J]. Cancer Lett, 2015, 359(1): 107-116.
[27] Suvà ML, Rheinbay E, Gillespie SM, et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells[J]. Cell, 2014, 157(3): 580-594.
[28] Narayanan A, Gagliardi F, Gallotti AL, et al. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1[J]. Cell Death Differ, 2019, 26(9): 1813-1831.
[29] Minata M, Audia A, Shi JF, et al. Phenotypic plasticity of invasive edge glioma stem-like cells in response to ionizing radiation[J]. Cell Rep, 2019, 26(7): 1893-1905.
[1] WEI Yanruoxue, LI Ziqi, LIU Chuncheng, LIU Xiaohan, ZHAO Ran, LIU Yukun. Intratumor heterogeneity of SP1 expression in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 89-94.
[2] LIU Chuncheng, LIU Xiaohan, WEI Yanruoxue, LI Ziqi, LIU Yukun, ZHAO Ran. Subcellular localization pattern of bromodomain containing 9 in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 24-30.
[3] YANG Xueyan, WU Yinping, LYU Li, ZHAO Zehua, MA Hangyu, LI Fengcai, WANG Kai, FAN Yuchen. Diagnostic value of dynamic changes of monocyte-to-lymphocyte ratio in acute-on-chronic hepatitis B liver failure [J]. Journal of Shandong University (Health Sciences), 2024, 62(3): 61-69.
[4] DIAO Yujie, LIN Lin, LI Wenxuan, WANG Zhouyang, JIANG Bei, HU Yingying, LIU Guangyi. Neutrophil-to-platelet ratio predicts adverse renal outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis and its synergistic multifactor optimization model [J]. Journal of Shandong University (Health Sciences), 2024, 62(2): 60-68.
[5] LIU Yan, LENG Shanshan, XIA Xiaona, DONG Hao, HUANG Chencui, MENG Xiangshui. Functional outcomes of 376 patients with supratentorial spontaneous intracerebral hemorrhage based on radiomic parameters [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 59-67.
[6] CHEN Rong, YANG Yue, YANG Zhixiang, SU Yaying, PANG Zhiying, WANG Dawei, CUI Shujun, YANG Fei. Texture analysis based on CT to predict the short-term outcomes of acute pulmonary embolism [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 78-85.
[7] HUA Yuefan, HE Keyao, ZHANG Jiahao, QIAN Mengfan, LIU Yiwen, KONG Jinyu, YANG Haijun, ZHOU Fuyou. Effects of high expressions of hypoxia inducible factor-1 and vascular endothelial growth factor induced by Fusobacterium nucleatum on survival and prognosis of patients with esophageal squamous cell carcinoma [J]. Journal of Shandong University (Health Sciences), 2023, 61(11): 59-67.
[8] ZHAO Qidi, WANG Kai, ZHAO Xiaogang, YAN Tao, WANG Yadong, DU Jiajun. Constructing and validating a prognostic model for patients with stage IIIB non-small cell lung cancer based on SEER database [J]. Journal of Shandong University (Health Sciences), 2023, 61(10): 23-37.
[9] ZHENG Su, CHEN Shuhua, LI Hua, DENG Jie, CHEN Chunhong, WANG Xiaohui, FENG Weixing, HAN Xiaodi, ZHANG Yujia, LI Na, LI Mo, FANG Fang. Correlation between EEG variations and BASED evaluation of the efficacy of ACTH treatment in 54 cases of infantile spasms [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 91-96.
[10] WANG Lihui, GAO Min, KONG Beihua. Angiosarcoma of the uterus: a report of 2 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 108-112.
[11] HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43.
[12] ZHANG Yufeng, XU Min, XING Xiuli, PANG Shuguang, HU Keqing. Epidemiological characteristics of 689 patients with non-ST-segment elevation myocardial infarction [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 118-122.
[13] LI Linlin, WANG Kai. Prediction of hepatocellular carcinoma prognostic genes based on bioinformatics [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 50-58.
[14] KONG Linxiaoyu, SUN Shuzhen, YU Lichun, JIA Mengwen. Analysis of 5-year survival rate and prognosis in 188 children with systemic lupus erythematosus [J]. Journal of Shandong University (Health Sciences), 2022, 60(12): 69-76.
[15] Zhenguo SUN,Hui TIAN. Optimization of the procedures in minimally invasive esophagectomy: the Qilu practices [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 33-37.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd